These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 32382041

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.
    Hu W, Zheng S, Guo H, Dai B, Ni J, Shi Y, Bian H, Li L, Shen Y, Wu M, Tian Z, Liu G, Hossain MA, Yang H, Wang D, Zhang Q, Yu J, Birnbaumer L, Feng J, Yu D, Yang Y.
    Hepatology; 2021 Feb; 73(2):674-691. PubMed ID: 32335942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Zhou Q, Huang T, Jiang Z, Ge C, Chen X, Zhang L, Zhao F, Zhu M, Chen T, Cui Y, Li H, Yao M, Li J, Tian H.
    Oncogene; 2020 Mar; 39(10):2140-2155. PubMed ID: 31819169
    [Abstract] [Full Text] [Related]

  • 6. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
    Shali S, Yu J, Zhang X, Wang X, Jin Y, Su M, Liao X, Yu J, Zhi X, Zhou P.
    J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.
    Wang LL, Luo J, He ZH, Liu YQ, Li HG, Xie D, Cai MY.
    Cell Death Dis; 2021 Nov 05; 12(11):1052. PubMed ID: 34741044
    [Abstract] [Full Text] [Related]

  • 9. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination.
    Peng L, Wu T, Liu Y, Zhao D, He W, Yuan Y.
    Cell Oncol (Dordr); 2024 Jun 05; 47(3):987-1004. PubMed ID: 38315284
    [Abstract] [Full Text] [Related]

  • 10. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X.
    J Hepatol; 2020 May 05; 72(5):909-923. PubMed ID: 31899205
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z, Hou Q, Guo H.
    Exp Cell Res; 2020 Dec 01; 397(1):112311. PubMed ID: 32991874
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR, Fang D, Di MP, Guan JL, Wang G, Liu L, Sheng JQ, Tian DA, Li PY.
    Int J Med Sci; 2020 Dec 01; 17(9):1224-1234. PubMed ID: 32547318
    [Abstract] [Full Text] [Related]

  • 14. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 01; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
    Xiong B, Huang J, Liu Y, Zou M, Zhao Z, Gong J, Wu X, Qiu C.
    Cell Oncol (Dordr); 2021 Apr 01; 44(2):329-343. PubMed ID: 33074477
    [Abstract] [Full Text] [Related]

  • 17. 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop.
    Zheng S, Ni J, Li Y, Lu M, Yao Y, Guo H, Jiao M, Jin T, Zhang H, Yuan A, Wang Z, Yang Y, Chen Z, Wu H, Hu W.
    Pharmacol Res; 2021 Jul 01; 169():105685. PubMed ID: 34022398
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.